MedTech Terms
    The authoritative reference
    All terms
    StandardsQuality SystemManufacturing & Supply

    ISO 11607-1/-2

    Standards for sterile barrier systems for terminally sterilized medical devices.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed September 19, 2026

    Definition

    ISO 11607-1 specifies requirements for materials, sterile barrier systems, and packaging systems. ISO 11607-2 covers validation requirements for forming, sealing, and assembly processes. The sterile barrier system must allow sterilization, keep the device sterile until use and allow aseptic presentation. Part 1 requires testing of material properties, seal strength, package integrity (such as dye penetration or bubble tests) and stability, often through accelerated and real-time aging. Part 2 requires installation, operational and performance qualification of sealing and forming processes. Both parts were amended in 2023.
    What the regulation says
    ISO 11607-1 provides requirements for packaging materials, pre-formed sterile barrier systems, and sterile barrier systems, ensuring they maintain sterility of terminally sterilized medical devices to the point of use. ISO 11607-2 specifies requirements for the development and validation of processes for packaging medical devices, emphasizing that packaging must be repeatable and reproducible. Both parts are recognized by regulatory bodies like the FDA as consensus standards, supporting compliance with essential requirements for device packaging.

    What this means in practice

    Co-cited with sterilization standards in FDA Recognized Standards; packaging changes commonly drive Letter-to-File vs new submission decisions.

    Examples

    • A manufacturer designs a new sterile barrier system for an implantable medical device, ensuring the materials meet the requirements of ISO 11607-1 for biocompatibility and shelf life.
    • A company performs extensive process validation for its heat-sealing operation, collecting data to demonstrate that seals consistently meet strength and integrity specifications as required by ISO 11607-2.
    • During a regulatory audit, a company presents its packaging design and validation reports, demonstrating compliance with ISO 11607 requirements for a new sterile surgical tool.
    Common pitfalls
    • •A common mistake is failing to consider the entire life cycle of the device when designing packaging, leading to sterility breaches during transport or storage.
    • •Companies often underestimate the rigor required for process validation under ISO 11607-2, resulting in inadequate documentation and potential regulatory findings.
    • •Assuming that a packaging material approved for one device is suitable for another without re-evaluation is a frequent error.
    • •Neglecting to perform ongoing monitoring and revalidation of packaging processes can lead to undetected issues over time.
    • •Failing to conduct comprehensive usability testing of the sterile barrier system can result in issues during aseptic presentation by end-users.

    Frequently asked questions

    The primary goal of ISO 11607 is to ensure that terminally sterilized medical devices remain sterile until the point of use, protecting patient safety.

    Related terms

    Grouped by theme
    Cited by

    Where this term appears across MedTech Terms.

    Sources

    3 sources

    Sources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

    Tier 1Binding law and standards· 2Tier 2Regulator guidance and consensus· 1
    Link health: 3 verified· last checked 2026-06-20
    ISO·1IEC·1AAMI·1
    1. 1
      ISO 11607-1
      Tier 1 Verified
      ISOiso.org
    2. 2
      IEC Webstore - Medical Equipment
      Tier 1 Verified
      IECwebstore.iec.ch
    3. 3
      AAMI Standards
      Tier 2 Verified
      AAMIaami.org

    Inline markers like [1] jump to the matching reference above.